BSECompany Update1 Oct 2026 · 1 Oct 2026, 11:35 am

Cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director of the company upon completion of his second term of appointment as an Independent Director

KMS Medisurgi Ltd · 540468

✦ AI SummaryMgmt Change

KMS Medisurgi Ltd announces the cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director, effective September 30, 2026, upon completion of his second term.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

KMS Medisurgi Ltd - 540468 - Announcement under Regulation 30 (LODR)-Cessation

Attachments (1)

📄

0ccd91d0-0d7e-4a0d-8330-f911fd8c1124.pdf

pdf

Download →
View document text
KMS MEDISURGI LIMITED ® Plot No-297/301 May Building, Gr. Floor Marine lines (EAST), Princess Street, Mumbai 400 002 Maharashtra (India) ™ J CIN: L51397MH1999PLC119118 Website: www.kmsgroup.in | E-mail Id: cskms99@gmail,com Tel: 022-66107700/22, 022-67498822 | Fax: +91-22-22061111 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400001 Ref.: KMS Medisurgi Limited (Scrip Code: 540468) Subject: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Intimation regarding cessation of Independent Director Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that Mr. Kamlesh Rajani Chunilal (DIN: 07588417) has completed his second term as an Independent Director of the Company and, consequently, has ceased to be a Director of the Company with effect from the close of business hours on September 30, 2026. The Board of Directors and the Management of the Company place on record their sincere appreciation for the valuable contributions, guidance and services rendered by Mr. Kamlesh Rajani Chunilal during his tenure as an Independent Director of the Company. The requisite details regarding the aforesaid cessation of the Independent Director, as prescribed under Clause 7 of Para A of Part A of Schedule Ill of the SEBI Listing Regulations, read with the SEBI Circular dated July 13, 2023, are enclosed herewith as Annexure A. The above information is also available on the website of the Company at www.kmsgroup.in. You are requested to kindly take the above information on record. Thanking you, Yours faithfully, For KMS MEDISURGI LIMITED w DIRECTOR Siddharth Kanakia Managing Director DIN: 07595098 Place: Mumbai Date: October 01, 2026 ANNEXUR-E A Details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Circulars dated July 13, 2023 and November 11, 2024 Cessation of Mr. Kamlesh Rajani Chunilal (DIN: 07588417) as Independent Director of the Company Name of Director Mr. Kamlesh Rajani Chunilal (DIN: 07588417) Reason for Change (cessation) Cessation of Mr. Kamlesh Rajani Chunilal as an Independent Director of the Company upon completion of his second term of appointment as an Independent Director. Date of Cessation September 30, 2026 Disclosure of relationship between directors | Not Applicable Directorship in any other listed companies Nil Board Committee Update Nil Information required pursuant to BSE Circular | Not Applicable no. LIST/COMP/14/2018-19 and the NSE Circular no. NSE/ CML/2018/24, both dated 20 June 2018